Derma Sciences, Inc. Common Stock (DE)
DSCI
DSCI was delisted on the 23rd of February, 2017.
53 hedge funds and large institutions have $184M invested in Derma Sciences, Inc. Common Stock (DE) in 2013 Q2 according to their latest regulatory filings, with 53 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
96% less call options, than puts
Call options by funds: $5K | Put options by funds: $125K
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Barclays
London,
United Kingdom
| $3K | +$2.6K | +202 | New |
|
|
RFC
52
Russell Frank Company
Seattle,
Washington
| $1K | +$771 | +60 | New |
|
53
Wells Fargo
San Francisco,
California
| – | +$26 | +2 | New |
|
DSCI Hedge Fund Activity: Q2 2013 in Review
53 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Derma Sciences, Inc. Common Stock (DE) (DSCI) for Q2 2013, worth a combined $184M.
Buyers outnumbered sellers: 53 funds opened new DSCI positions and 0 closed out — a net gain of 53 holders — while 0 added to existing stakes and 0 trimmed.
- 53 institutional investors held Derma Sciences, Inc. Common Stock (DE) (DSCI) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $184M of Derma Sciences, Inc. Common Stock (DE) stock for Q2 2013.
- 53 funds opened new Derma Sciences, Inc. Common Stock (DE) positions in Q2 2013 and 0 closed out, a net change of +53 holders.
Based on aggregated 13F filings for Q2 2013.